Ads
related to: Pfizer
Search results
Pfizer Inc. Just Beat EPS By 61%: Here's What Analysts Think Will Happen Next
Simply Wall St. via Yahoo Finance· 22 hours agoPfizer Inc. (NYSE:PFE) just released its first-quarter report and things are looking bullish. It was...
Pfizer announces 500 million euros investment in France
Reuters via Yahoo Finance· 2 hours agoPARIS, May 12 (Reuters) - U.S. pharmaceutical and healthcare giant Pfizer announced on Sunday a 500 million-euro ($538 million) investment in France for research and development ...
Pfizer Inc's Dividend Analysis
GuruFocus.com via Yahoo Finance· 4 days agoPfizer Inc (NYSE:PFE) recently announced a dividend of $0.42 per share, payable on 2024-06-14, with the ex-dividend date set for 2024-05-09. As investors...
Pfizer agrees to settle over 10K lawsuits linking Zantac to cancer
New York Post· 4 days agoPfizer has agreed to settle more than 10,000 lawsuits which alleged that the company failed to warn...
Pfizer agrees to settle 10K Zantac lawsuits, as GSK trial links heartburn drug to cancer
BenefitsPRO· 3 days agoPfizer has agreed to settle more than 10,000 cases accusing it of hiding the cancer risks of its...
Is Pfizer Stock Fully Valued At $28?
Forbes· 5 days agoPfizer (NYSE: PFE) reported its Q1 results last week, with revenues and earnings beating the street estimates.
Decoding Pfizer Inc (PFE): A Strategic SWOT Insight
GuruFocus.com via Yahoo Finance· 2 days agoStrengths highlight Pfizer's robust product portfolio and global market presence. Weaknesses underscore the challenges in revenue fluctuations and patent...
A Struggling Pfizer Looks for Help From a Wall Streeter
Barrons.com· 2 days agoAs the big drugmaker tries to turn its fortunes around by focusing on oncology, it has turned to a...
Jacob Rees-Mogg claims UK government 'downplayed' risks of AstraZeneca COVID vaccine
Yahoo News UK· 2 days agoIn the first year, vaccinations were estimated to have prevented 19.8 million COVID-19 deaths...
Pfizer Is Adding a Wall Street Analyst to Its C-Suite. What He Thinks the Company Needs to Do.
Barrons.com· 6 days agoSTOCK ALERT Andrew Baum, the prominent Wall Street drug company analyst, has never been much of a...